Abstract: Multifocal-Electroretinogram (mfERG) is a relatively new diagnostic method introduced by Sutter and Tran in 1922. This technique provides a topographic measurement of retinal activity and enables topographic mapping of retinal function in the central 40-50? of the retina.
In this presentation the authors summarize their experience from the clinical application of mfERG in the diagnosis and follow-up of hereditary macular diseases (eg Stargardt disease, Juvenile retinoschisis). The authors also support that the use of mfERG enables to diagnose and monitor the development of toxic retinopathy due to hydroxychloquine as also to follow-up objectively the efficacy of surgical or non-surgical treatment for retinal diseases, such as macular hole, epiretinal membrane, macular edema due to age-related macular degeneration (ARMD), diabetic retinopathy, central retinal vein occlusion (CRVO), or central serous chorioretinopathy (CSCR).

Brief Biography of the Speaker:
Marilita M. Moschos graduated the Pharmacy School of the University of Patras and the Medical School of the University of Athens. She is actually working as a senior lecturer of Department of Ophthalmology of Athens University where she has the clinical and scientific co-responsibility of the Laboratory of Electrophysiology of Vision and the department of Glaucoma. She authored or co-authored over 45 scientific papers in pubmed reviewed journals and presented over 50 at international conferences, in some of them as invited speaker. She also wrote the chapter on 'Multifocal-Electroretinogram in retinal vascular diseases' in the annual edition of SFO (Societe Francaise d'Ophtalmologie). Finally she is a member of many international ophthalmological societies and reviewer in several ophthalmological journals, like, Clinical and Experimental Ophthalmology, Expert Review of Ophthalmology, Journal of Neuroscience Methods, Graefe's Archive for Clinical and Experimental Ophthalmology, BMC Ophthalmology, Clinical Ophthalmology, Indian Journal of Ophthalmology and others.